B
Biohaven Ltd. (BHVN)
NYQ – Real Time Price. Currency in USD
14.31
-0.17 (-1.21%)
Market open: Aug 12, 2026, 10:20 AM EDT
14.21
-0.28 (-1.93%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
Find any stock by ticker or company name

NYQ – Real Time Price. Currency in USD
14.31
-0.17 (-1.21%)
Market open: Aug 12, 2026, 10:20 AM EDT
14.21
-0.28 (-1.93%)
Previous after-hours: Aug 11, 2026, 7:34 PM EDT
| Breakdown | |
|---|---|
| 11.21% | % of Shares Held by All Insider |
| 93.50% | % of Shares Held by Institutions |
| 105.30% | % of Float Held by Institutions |
| 381 | Number of Institutions Holding Shares |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Blackrock Inc. | 13.21M | 2026-06-30 | 8.77% | $191.42M |
| State Street Corporation | 6.95M | 2026-06-30 | 4.61% | $100.66M |
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 3.78M | 2026-06-30 | 2.51% | $54.73M |
| iShares Trust-iShares Russell 2000 ETF | 3.49M | 2026-06-30 | 2.32% | $50.64M |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 2.18M | 2026-06-30 | 1.45% | $31.59M |
| JANUS INVESTMENT FUND-Janus Henderson Global Life Sciences Fund | 1.33M | 2026-06-30 | 0.89% | $19.32M |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.27M | 2026-03-31 | 0.84% | $18.39M |
| T. Rowe Price Health Sciences Fund, Inc. | 1.23M | 2026-03-31 | 0.82% | $17.80M |
| iShares Trust-iShares Russell 2000 Growth ETF | 1.23M | 2026-06-30 | 0.82% | $17.79M |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.17M | 2026-05-31 | 0.78% | $16.94M |
| SmallCap World Fund Inc | 1.17M | 2026-03-31 | 0.78% | $16.93M |
| JANUS INVESTMENT FUND-Janus Henderson Triton Fund | 1.16M | 2026-06-30 | 0.77% | $16.84M |
| JANUS INVESTMENT FUND-Janus Henderson Venture Fund | 999,308 | 2026-05-31 | 0.66% | $16.04M |
| iShares Trust-iShares Biotechnology ETF | 912,637 | 2026-04-30 | 0.61% | $9.91M |
| Simplify Exchange Traded Funds-Simplify Health Care ETF | 908,165 | 2026-03-31 | 0.60% | $9.86M |
| abrdn Life Sciences Investors | 693,452 | 2025-12-31 | 0.46% | $6.68M |